ALGORAE PHARMA ORDINARY (1AI) Short Interest
ALGORAE PHARMA ORDINARY (ASX:1AI) had 0.00% of shares reported as short positions as of 11 July 2026, representing 16,823 shares. ALGORAE PHARMA ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Unlock advanced features: Custom dashboards, portfolio tracking, real-time alerts, and more
Algorae Pharmaceuticals
Algorae Pharmaceuticals Limited focuses on the development and commercialization of innovative pharmaceuticals and biotechnology products. The company leverages cutting-edge research to address unmet medical needs across various therapeutic areas. Its market position is bolstered by a robust pipeline of drugs that target specific industry demands, making it a key player in pharmaceutical innovation.